These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24143378)

  • 1. Antifibrotic effects of immobilized hyaluronidase in repeated bleomycin-induced lesions of the alveolar epithelium.
    Dygai AM; Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2013 Aug; 155(4):501-6. PubMed ID: 24143378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic activity of hyaluronidase immobilized on polyethylenoxide under conditions of bleomycin-induced pneumofibrosis.
    Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2013 Jan; 154(3):388-92. PubMed ID: 23484207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory and antifibrotic effects of a combination of spiperone and immobilized hyaluronidase on partially reversible and irreversible toxic pneumofibrosis.
    Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Reihard DV; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Dygai AM
    Bull Exp Biol Med; 2013 Nov; 156(1):53-8. PubMed ID: 24319728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effect of combined treatment with neuroleptic drug and immobilized hyaluronidase in pulmonary fibrosis.
    Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Semiglazova TA
    Bull Exp Biol Med; 2013 Jan; 154(3):329-33. PubMed ID: 23484193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immobilized hyaluronidase on stem and progenitor cells in pulmonary fibrosis.
    Dygai AM; Skurikhin EG; Khmelevskaya ES; Ermakova NN; Reztsova AM; Pershina OV; Krupin VA; Stepanova IE; Reztsova VM; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2014 Feb; 156(4):590-4. PubMed ID: 24771454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.
    Skurikhin EG; Pershina OV; Reztsova AM; Ermakova NN; Khmelevskaya ES; Krupin VA; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Dygai AM
    PLoS One; 2015; 10(4):e0125065. PubMed ID: 25927611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis.
    Skurikhin E; Madonov P; Pershina O; Ermakova N; Pakhomova A; Widera D; Pan E; Zhukova M; Sandrikina L; Artamonov A; Dygai A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.
    Gurrieri C; Piazza F; Gnoato M; Montini B; Biasutto L; Gattazzo C; Brunetta E; Cabrelle A; Cinetto F; Niero R; Facco M; Garbisa S; Calabrese F; Semenzato G; Agostini C
    J Pharmacol Exp Ther; 2010 Mar; 332(3):785-94. PubMed ID: 19959748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic activity of conjugates based on amphiphilic pluronic F68 and hydrophobic pluronic L31 with hyaluronate-endo-β-N-acetylhexosaminidase in pulmonary fibrosis.
    Skurikhin EG; Reztsova AM; Ermakova NN; Krupin VA; Pershina OV; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Reykhard DV; Goldberg VE; Dygai AM
    Bull Exp Biol Med; 2014 May; 157(1):5-9. PubMed ID: 24906958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis.
    Germano D; Blyszczuk P; Valaperti A; Kania G; Dirnhofer S; Landmesser U; Lüscher TF; Hunziker L; Zulewski H; Eriksson U
    Am J Respir Crit Care Med; 2009 May; 179(10):939-49. PubMed ID: 19234103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of the anti-inflammatory and antifibrotic activity of a sympatholytic agent during toxic pulmonary fibrosis.
    Skurikhin EG; Khmelevskaya ES; Pershina OV; Andreeva TV; Ermolaeva LA; Krupin VA; Ermakova NN; Reztsova AM; Stepanova IE; Dygai AM
    Bull Exp Biol Med; 2012 Sep; 153(5):638-43. PubMed ID: 23113245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized Liposomal Formulation Prevents Enhanced Drug Transfer from Fibrotic Lungs to the Systemic Circulation.
    Togami K; Kurasho K; Kanehira Y; Tada H; Chono S
    Curr Drug Deliv; 2021; 18(7):947-954. PubMed ID: 33372874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogenous Intrapulmonary Distribution of Aerosolized Model Compounds in Mice with Bleomycin-Induced Pulmonary Fibrosis.
    Togami K; Kanehira Y; Yumita Y; Ozaki H; Wang R; Tada H; Chono S
    J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):289-299. PubMed ID: 37843890
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms for hepatoprotective effects of hyaluronidase immobilized by the nanotechnology method of electron-beam synthesis.
    Dygai AM; Zyuzkov GN; Zhdanov VV; Udut EV; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Miroshnichenko LA; Khrichkova TY; Simanina EV; Stavrova LA; Chaikovskiy AV; Markova TS; Minakova MY; Gurto RV
    Bull Exp Biol Med; 2011 May; 151(1):74-8. PubMed ID: 22442807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of spiperone on mesenchymal multipotent stromal and hemopoietic stem cells under conditions of pulmonary fibrosis.
    Skurikhin EG; Khmelevskaya ES; Ermakova NN; Pershina OV; Reztsova AM; Krupin VA; Stepanova IE; Reztsova VM; Reikhart DV; Dygai AM
    Bull Exp Biol Med; 2014 May; 157(1):132-7. PubMed ID: 24913578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
    Wuyts WA; Willems S; Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Rinaldi M; Vanhooren HM; Geudens N; Verleden SE; Demedts MG; Thomeer M; Verbeken EK; Verleden GM
    Exp Lung Res; 2010 Dec; 36(10):602-14. PubMed ID: 20874225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis.
    Togami K; Ogasawara A; Irie S; Iwata K; Yamaguchi K; Tada H; Chono S
    Eur J Pharm Biopharm; 2022 Mar; 172():203-212. PubMed ID: 35183716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
    Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.
    Togami K; Chono S; Tada H
    J Pharm Sci; 2016 Mar; 105(3):1327-34. PubMed ID: 26886341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.